Oncology News | pharmaphorum

News

Merck and Pfizer’s immunotherapy combination gains Breakthro...

Merck and Pfizer have received a major boost to their immune-oncology alliance with a second FDA Breakthrough Therapy Designation for Bavencio, this time in combination with Pfizer’s Inlyta

News

Janssen jumps into CAR-T field with China’s Legend Biotech

J&J has struck a deal with Chinese biotech company Genscript, giving it entry to the global market for CAR-T therapies.

News

Roche pays $1.7 billion for cancer specialist Ignyta

Roche is to bolster its cancer pipeline with the $1.7 billion acquisition of Ignyta.

News

Takeda interested in next-generation immuno-oncology deals

Japanese firm wants to build presence in cancer

News

Roche/AbbVie drug could further improve prognosis in CLL

Roche/AbbVie’s cancer drug venetoclax, which is set to become standard of care in chronic lympocytic leukaemia, could further improve prognosis earlier in the disease according to a UK expe

News